Sagefield Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Sagefield Capital’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-29,600	Closed	-$549K	–	115
2023 Q3	$549K	Buy	+29,600	New	+$335K	0.08%	92

Sagefield Capital's ICPT Position: Q4 2023 in Review

Sagefield Capital sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 29,600 shares — an estimated $549K sold.

Sagefield Capital first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $549K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Sagefield Capital reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Sagefield Capital sold 29,600 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $549K.
Sagefield Capital first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
Sagefield Capital's Intercept Pharmaceuticals, Inc. position peaked at $549K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Sagefield Capital's 13F filing for Q4 2023, filed 14 Feb 2024.